Unraveling the role of gut microbiota and immune cells in thyroid cancer and tumor drug resistance
Abstract The gut microbiota (GM) and immune cells (IC) are increasingly recognized as key players in cancer development and progression. This study aimed to explore the potential mediating role of IC in the causal relationship between GM and thyroid cancer (TC) using Mendelian randomization (MR) ana...
Saved in:
| Main Authors: | Jiaqin Deng, Yihua Gu, Ming Yu, Yeqian Lai, Lihong Qiu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer
2024-11-01
|
| Series: | Discover Oncology |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s12672-024-01585-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut microbiota and breast cancer risk: a Mendelian randomization study stratified by ER status
by: Jian Yue, et al.
Published: (2025-08-01) -
Gut microbiota and risk of heart failure in European population—A comprehensive Mendelian randomization study
by: Liyan Huang, et al.
Published: (2025-08-01) -
Genetically proxied gut microbiota and cancer risk: a scoping review of Mendelian randomization studies
by: Yating Cui, et al.
Published: (2025-08-01) -
A two-sample Mendelian randomization study reveals the causal effects of statin medication on gut microbiota abundance in the European population
by: Peng Zhou, et al.
Published: (2024-12-01) -
Associations between the gut microbiota, immune cells, and different subtypes of epilepsy: A Mendelian randomization study
by: Xu Zhang, et al.
Published: (2025-08-01)